help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KOHLHÄUFL, M.
Right arrow Articles by HEYDER, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KOHLHÄUFL, M.
Right arrow Articles by HEYDER, J.

Am. J. Respir. Crit. Care Med., Volume 160, Number 3, September 1999, 913-918

Noninvasive Diagnosis of Emphysema
Aerosol Morphometry and Aerosol Bolus Dispersion in Comparison to HRCT

MARTIN KOHLHÄUFL, PETER BRAND, CLEMENS ROCK, THORSTEN RADONS, GERHARD SCHEUCH, THOMAS MEYER, HOLGER SCHULZ, KLAUS J. PFEIFER, KARL HÄUSSINGER, and JOACHIM HEYDER

Clinical Research Group "Aerosols in Medicine" of the GSF, Institute for Inhalation Biology and Center for Respiratory Medicine, Munich-Gauting; and Department of Radiology, Klinikum Innenstadt, University of Munich, Munich, Germany

Aerosol-derived airway morphometry (ADAM) and aerosol bolus dispersion (ABD) test are altered in patients with emphysema. We examined the diagnostic power of these aerosol methods in comparison with the noninvasive "gold-standard" HRCT in 50 consecutive patients with various lung diseases. The severity of airflow limitation was mild to moderate in the group of patients without emphysema and moderate to severe in the group of patients with HRCT-confirmed emphysema (FEV1, 78 ± 23% pred versus 53 ± 33% pred; p < 0.001). Among all lung function parameters under consideration ADAM showed the highest sensitivity and specificity for separating patients with emphysema from those without emphysema (area under the operating characteristics curve: pROC, 0.92), followed by ABD (pROC, 0.90), a marker for ventilation inhomogeneities. In patients with HRCT-confirmed macroscopic emphysema, peripheral air-space dimensions (EAD) at a relative volumetric lung depth Vpr of 0.20 measured by ADAM were 155% larger, and bolus dispersion (ABD) at a lung depth of Vp 600 ml was 53% larger than those observed in patients with other lung diseases (EAD = 0.84 ± 0.53 mm versus 0.33 ± 0.10 mm, p < 0.0001; ABD = 706 ± 154 cm3 versus 462 ± 109 cm3; p < 0.0001). EAD showed a significant correlation with the HRCT visual score (r = 0.78, p = 0.01). ABD showed weak significant correlations with all HRCT parameters under consideration (visual score, pixel density, mean lung density) (r = 0.45 to 0.66; p < 0.05). ADAM and ABD are powerful tools for the noninvasive diagnosis of macroscopic emphysema.




This article has been cited by other articles:


Home page
 Eur Respir JHome page
Y. Higashimoto, Y. Yamagata, T. Iwata, M. Okada, T. Ishiguchi, H. Sato, M. Masuda, and H. Itoh
Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients
Eur. Respir. J., May 1, 2005; 25(5): 885 - 890.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
S. B. Shaker, N. Maltbaek, P. Brand, S. Haeussermann, and A. Dirksen
Quantitative computed tomography and aerosol morphometry in COPD and {alpha}1-antitrypsin deficiency
Eur. Respir. J., January 1, 2005; 25(1): 23 - 30.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1999 American Thoracic Society